RLAY Stock Analysis: Buy, Sell, or Hold?
RLAY - Relay Therapeutics, Inc. Common Stock
$7.66
-0.05 (-0.65%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When RLAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RLAY shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RLAY shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RLAY is currently trading at $7.66, which is considered slightly low relative to its 30-day fair value range of $7.61 to $8.40.
Technical Outlook: Technically, RLAY is in a strong uptrend. Immediate support is located at $7.01, while resistance sits at $8.63.
Market Sentiment: RLAY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $14.55 (+88.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RLAY is in a strong uptrend. Immediate support is located at $7.01, while resistance sits at $8.63.
Market Sentiment: RLAY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $14.55 (+88.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$7.61 -
$8.40
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding RLAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 88.7% below Wall St target ($14.55)
Fair Price Analysis
30-Day Fair Range
$7.61 -
$8.40
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.01
Resistance Level
$8.64
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.71
Wall Street Target
$14.55
(+88.7%)
Revenue Growth (YoY)
-23.3%
Last updated: January 30, 2026 10:05 PM ET
Data refreshes hourly during market hours. Next update: 11:05 PM
Data refreshes hourly during market hours. Next update: 11:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced RLAY Option Strategies
Professional options setups generated by AI based on today's RLAY price and gamma walls.
